Survival to Discharge With Good Neurologic Outcome Among in Hospital Cardiac Arrest PatientsNCT07899645
Therapeutic Outcomes of In-Hospital Resuscitation of Patients Admitted to the Internal Medicine Wards
An observational study of Survival to Discharge With Good Neurologic Outcome Among in Hospital Cardiac Arrest Patients, run by Meir Medical Center.
Trial summary
In-hospital cardiac arrest is a common phenomenon associated with high mortality rates. In the United States, 290,000 cases of in-hospital cardiac arrest among adult patients occur annually (1). The mean patient age is 66 years, and 58% are male. Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Survival to Discharge With Good Neurologic Outcome Among in Hospital Cardiac Arrest Patients
- How many people
- 2,000 participants
- Where
- No sites listed yet
- Study dates
- 1 Jan 2027to 1 Jan 2029
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- Adult, Older adult
Study population: All patients aged 18-99 who underwent resuscitation during their hospitalization in the Department of Internal Medicine at Meir Hospital between January 2017 and October 2026.
Inclusion Criteria:All patients aged 18-99 who underwent resuscitation during their hospitalization in the Department of Internal Medicine at Meir Hospital between January 2017 and October 2026.
-
Exclusion Criteria: Patients who underwent resuscitation during hospitalization in wards other than internal medicine departments, or for whom data is missing.
-
About this study
Official title: Therapeutic Outcomes of In-Hospital Resuscitation of Patients Admitted to the Internal Medicine Wards: A Retrospective Study
In-hospital cardiac arrest is a common phenomenon associated with high mortality rates. In the United States, 290,000 cases of in-hospital cardiac arrest among adult patients occur annually (1). The mean patient age is 66 years, and 58% are male. In the majority of cases (81%), the initial cardiac rhythm was non-shockable (asystole, PEA). The primary cause of arrest was cardiac (50-60%), followed by respiratory causes (15-40%) (1). Survival rates for these patients have risen over the past two decades; according to the GWTG-R registry, survival to hospital discharge was 25% in 2017, with 85% of survivors demonstrating a favorable neurological outcome (CPC score of 1 or 2; see details under "Objectives"). It is important to note that these figures vary across different countries, potentially due to differences in the patient populations studied (e.g., survival odds are better for cardiac-related arrest than for respiratory-related arrest; distinctions between internal medicine, surgical, cardiac, and trauma patients; the location of resuscitation-ICU vs. general ward, etc.) as well as cultural, social, and religious factors (e.g., awareness of DNR/DNI orders among the public and medical staff, specific national legislation, and patient preferences). ...the patient and their family regarding end-of-life care due to religious, cultural, or social reasons, etc.).
The GO FAR score (Good Outcome Following Attempted Resuscitation) is a clinical prediction tool that estimates the likelihood of survival to hospital discharge with a good neurological outcome (CPC score of 1) for patients who have undergone in-hospital resuscitation. This score was developed using data from 51,000 patients across 366 hospitals, based on the GWTG-R registry. It incorporates data known prior to cardiac arrest, enabling the medical team, the patient, and the family to formulate a plan in advance regarding the course of action should the patient experience in-hospital cardiac arrest. The data points include age, neurological status upon admission, multisystem trauma, acute stroke, hematologic-oncologic disease or metastatic cancer, sepsis with bacteremia, non-cardiac reason for admission, liver failure, admission from a nursing facility, hypotension or shock upon admission, renal failure, respiratory failure, and pneumonia upon admission. Subsequently, the GO FAR 2 score was developed; while it included the same data points, it slightly modified the scoring method and also incorporated a CPC score of 2 (2,3).
We aim to examine survival rates to discharge with a good neurological outcome following in-hospital resuscitation... At Meir Hospital, we are focusing on a specific patient population: those hospitalized in internal medicine wards. This group generally has a lower likelihood of surviving with intact neurological function (due to factors such as advanced age, non-cardiac causes of arrest, and parameters contributing to a "GO FAR" score that reflects a poor prognosis). Our working hypothesis is that the success rate of resuscitation for these patients is typically very low; attempting it may cause suffering to the patient and their family without offering a reasonable chance of survival with a favorable neurological outcome. Beyond this point-which we consider paramount for the patient-resuscitation attempts with poor prospects entail other consequences: financial costs, extended hospital stays, increased workload for medical and nursing staff, and reduced resource availability for other patients with better recovery prospects, among others. Carefully selecting patients with a higher likelihood of successful in-hospital resuscitation would not only improve outcomes but also prevent unnecessary suffering. To formulate a plan for the informed selection of these patients, this study aims to collect relevant data.
What is being measured
The primary outcome is the main question the study is designed to answer.
survival to discharge
The precentage of patients who underwent in hospital cardiac arrest and survived to hopsital discharge
Measured: One year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Oct 2026
- Study start1 Jan 2027 (estimated)
- Primary completion1 Jan 2027 (estimated)
- Study completion1 Jan 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Survival to Discharge With Good Neurologic Outcome Among in Hospital Cardiac Arrest PatientsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 2,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Meir Medical Center
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, sara dichtwald, Meir Medical Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07899645
- Sponsor's protocol ID
- MMC-0413-26
- Status last verified
- Oct 2026
- First submitted
- 14 Oct 2026
- Last updated
- 27 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 27 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Therapeutic Outcomes of In-Hospital Resuscitation of Patients Admitted to the Internal Medicine Wards: A Retrospective Study
- ClinicalTrials.gov ID
- NCT07899645
- Acronym / sponsor ID
- MMC-0413-26
- Conditions
- Survival to Discharge With Good Neurologic Outcome Among in Hospital Cardiac Arrest Patients
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 2,000 participants (estimated)
- Lead sponsor
- Meir Medical CenterUniversity, hospital or other
- Study start
- 1 Jan 2027 (estimated)
- Primary completion
- 1 Jan 2027 (estimated)
- Study completion
- 1 Jan 2029 (estimated)
- First posted
- 27 Oct 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In-hospital cardiac arrest is a common phenomenon associated with high mortality rates. In the United States, 290,000 cases of in-hospital cardiac arrest among adult patients occur annually (1). The mean patient age is 66 years, and 58% are male. In the majority of cases (81%), the initial cardiac rhythm was non-shockable (asystole, PEA). The primary cause of arrest was cardiac (50-60%), followed by respiratory causes (15-40%) (1). Survival rates for these patients have risen over the past two decades; according to the GWTG-R registry, survival to hospital discharge was 25% in 2017, with 85% of survivors demonstrating a favorable neurological outcome (CPC score of 1 or 2; see details under "Objectives"). It is important to note that these figures vary across different countries, potentially due to differences in the patient populations studied (e.g., survival odds are better for cardiac-related arrest than for respiratory-related arrest; distinctions between internal medicine, surgical, cardiac, and trauma patients; the location of resuscitation-ICU vs. general ward, etc.) as well as cultural, social, and religious factors (e.g., awareness of DNR/DNI orders among the public and medical staff, specific national legislation, and patient preferences). ...the patient and their family regarding end-of-life care due to religious, cultural, or social reasons, etc.).
The GO FAR score (Good Outcome Following Attempted Resuscitation) is a clinical prediction tool that estimates the likelihood of survival to hospital discharge with a good neurological outcome (CPC score of 1) for patients who have undergone in-hospital resuscitation. This score was developed using data from 51,000 patients across 366 hospitals, based on the GWTG-R registry. It incorporates data known prior to cardiac arrest, enabling the medical team, the patient, and the family to formulate a plan in advance regarding the course of action should the patient experience in-hospital cardiac arrest. The data points include age, neurological status upon admission, multisystem trauma, acute stroke, hematologic-oncologic disease or metastatic cancer, sepsis with bacteremia, non-cardiac reason for admission, liver failure, admission from a nursing facility, hypotension or shock upon admission, renal failure, respiratory failure, and pneumonia upon admission. Subsequently, the GO FAR 2 score was developed; while it included the same data points, it slightly modified the scoring method and also incorporated a CPC score of 2 (2,3).
We aim to examine survival rates to discharge with a good neurological outcome following in-hospital resuscitation... At Meir Hospital, we are focusing on a specific patient population: those hospitalized in internal medicine wards. This group generally has a lower likelihood of surviving with intact neurological function (due to factors such as advanced age, non-cardiac causes of arrest, and parameters contributing to a "GO FAR" score that reflects a poor prognosis). Our working hypothesis is that the success rate of resuscitation for these patients is typically very low; attempting it may cause suffering to the patient and their family without offering a reasonable chance of survival with a favorable neurological outcome. Beyond this point-which we consider paramount for the patient-resuscitation attempts with poor prospects entail other consequences: financial costs, extended hospital stays, increased workload for medical and nursing staff, and reduced resource availability for other patients with better recovery prospects, among others. Carefully selecting patients with a higher likelihood of successful in-hospital resuscitation would not only improve outcomes but also prevent unnecessary suffering. To formulate a plan for the informed selection of these patients, this study aims to collect relevant data.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- All patients aged 18-99 who underwent resuscitation during their hospitalization in the Department of Internal Medicine at Meir Hospital between January 2017 and October 2026.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
survival to discharge
Time frame: One year
The precentage of patients who underwent in hospital cardiac arrest and survived to hopsital discharge
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Oct 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Survival to Discharge With Good Neurologic Outcome Among in Hospital Cardiac Arrest Patients, run by Meir Medical Center.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 27 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
survival to discharge (time frame: One year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Oct 2026; AzTrials last refreshed its copy on 8 Nov 2026.